Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD
2022 · Hepatology · 116 citations
https://doi.org/10.1002/hep.32568
M
Michael O. Idowu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
203
Papers
4.8K
Citations
40
h-index
76
i10-index
Michael O. Idowu is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Breast Cancer Treatment Studies. The author has an h-index of 40, co-authored 173 publications.
ORCID: 0000-0002-7416-5444Papers by this author
worksMolecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
2013 · Journal of Translational Medicine · 104 citations
https://doi.org/10.1186/1479-5876-11-145
An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis
2018 · Scientific Reports · 76 citations
https://doi.org/10.1038/s41598-018-30457-y
Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance
2018 · The American Journal of Cardiology · 55 citations
https://doi.org/10.1016/j.amjcard.2018.10.027
Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratories.
2010 · PubMed · 40 citations
https://doi.org/10.5858/134.5.728
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure
2011 · Journal of Translational Medicine · 19 citations
https://doi.org/10.1186/1479-5876-9-35
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat